ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,740,972 | -21.1% | 385,441 | +2.1% | 0.00% | -20.0% |
| Q2 2023 | $17,407,109 | +532.6% | 377,349 | +449.9% | 0.01% | +400.0% |
| Q1 2023 | $2,751,623 | -16.5% | 68,619 | -3.5% | 0.00% | 0.0% |
| Q4 2022 | $3,294,063 | +28.1% | 71,100 | +14.5% | 0.00% | 0.0% |
| Q3 2022 | $2,571,000 | -32.0% | 62,108 | -2.0% | 0.00% | 0.0% |
| Q2 2022 | $3,779,000 | -11.2% | 63,352 | +8.1% | 0.00% | 0.0% |
| Q1 2022 | $4,255,000 | -91.0% | 58,592 | -89.5% | 0.00% | -90.9% |
| Q4 2021 | $47,101,000 | -25.8% | 560,140 | -20.4% | 0.01% | -31.2% |
| Q3 2021 | $63,437,000 | +46.7% | 703,364 | +55.1% | 0.02% | +45.5% |
| Q2 2021 | $43,253,000 | -16.9% | 453,626 | -0.8% | 0.01% | -21.4% |
| Q1 2021 | $52,068,000 | -35.4% | 457,302 | -21.4% | 0.01% | -39.1% |
| Q4 2020 | $80,563,000 | +271.6% | 581,980 | +120.7% | 0.02% | +228.6% |
| Q3 2020 | $21,678,000 | +1164.8% | 263,755 | +1103.2% | 0.01% | +600.0% |
| Q2 2020 | $1,714,000 | +170.3% | 21,922 | +53.6% | 0.00% | – |
| Q1 2020 | $634,000 | +122.5% | 14,272 | +113.7% | 0.00% | – |
| Q4 2019 | $285,000 | -6.2% | 6,678 | -6.1% | 0.00% | – |
| Q3 2019 | $304,000 | -35.2% | 7,113 | -3.7% | 0.00% | – |
| Q2 2019 | $469,000 | -11.5% | 7,389 | -3.3% | 0.00% | – |
| Q1 2019 | $530,000 | +3.5% | 7,643 | -35.1% | 0.00% | – |
| Q4 2018 | $512,000 | -34.9% | 11,776 | +14.3% | 0.00% | – |
| Q3 2018 | $786,000 | -90.7% | 10,302 | -90.6% | 0.00% | -100.0% |
| Q2 2018 | $8,412,000 | +1807.5% | 109,426 | +1164.5% | 0.00% | – |
| Q1 2018 | $441,000 | -96.4% | 8,654 | -96.7% | 0.00% | -100.0% |
| Q4 2017 | $12,150,000 | -12.8% | 261,973 | +0.1% | 0.00% | -20.0% |
| Q3 2017 | $13,941,000 | -14.2% | 261,757 | +0.1% | 0.01% | 0.0% |
| Q2 2017 | $16,247,000 | +41.9% | 261,584 | +54.8% | 0.01% | +25.0% |
| Q1 2017 | $11,453,000 | +3.8% | 168,968 | +7.7% | 0.00% | 0.0% |
| Q4 2016 | $11,033,000 | -0.9% | 156,923 | -0.0% | 0.00% | 0.0% |
| Q3 2016 | $11,132,000 | +222540.0% | 156,924 | +295983.0% | 0.00% | – |
| Q2 2015 | $5,000 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |